Home › Graves Disease › Texas › Dallas
Graves Disease clinical trials in Dallas, TX
7 studies for Graves Disease are looking for participants at sites in and around Dallas (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease
RecruitingPhase 3
- Research Institute of Dallas, Dallas
Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease
RecruitingPhase 3
- Site-055, Dallas
- Site-020, Dallas
A Study to Learn About The Effects of Felzartamab on Thyroid Function and Its Safety in Adults With Graves' Disease Ages 18 to 75 Years Old
RecruitingPhase 2
- M3 Wake Research - Dallas, Dallas
Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease
RecruitingPhase 2
- Clinical Research Site, Dallas
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
RecruitingPhase 2
- Site Number - 1029, Dallas
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
RecruitingPhase 2
- Site Number - 1019, Dallas
Study of BHV-1300 in Graves' Disease
RecruitingPhase 1
- Site-109, Dallas
Graves Disease trials in other cities
- Miami, FL7 studies
- San Antonio, TX6 studies
- Houston, TX6 studies
- Torrance, CA3 studies
- Havelock, NC3 studies
- Las Vegas, NV3 studies
- Farmington Hills, MI3 studies
- Kansas City, MO3 studies
- McKinney, TX3 studies
- Memphis, TN3 studies
- Akron, OH3 studies
- Doral, FL3 studies
Other studies in Dallas
- Breast Cancer54 studies
- Non-Small Cell Lung Cancer52 studies
- Heart Failure42 studies
- Metastatic Cancer42 studies
- Cancer (all types)38 studies
- Prostate Cancer36 studies
- Colorectal Cancer33 studies
- Obesity31 studies
- Ovarian Cancer28 studies
- Bladder Cancer27 studies
- Lung Cancer27 studies
- Endometrial Cancer25 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.